Literature DB >> 24698507

Hemodynamic effects of nitroglycerin ointment in emergency department patients.

Bryn E Mumma1, Kapil R Dhingra2, Charley Kurlinkus1, Deborah B Diercks1.   

Abstract

BACKGROUND: Nitroglycerin ointment is commonly used in the treatment of emergency department (ED) patients with suspected acute heart failure (AHF) or suspected acute coronary syndrome (ACS), but its hemodynamic effects in this population are not well described.
OBJECTIVE: Our objective was to assess the effect of nitroglycerin ointment on mean arterial pressure (MAP) and systemic vascular resistance (SVR) in ED patients receiving nitroglycerin. We hypothesized that nitroglycerin ointment would result in a reduction of MAP and SVR in the acute treatment of patients.
METHODS: We conducted a prospective, observational pilot study in a convenience sample of adult patients from a single ED who were treated with nitroglycerin ointment. Impedance cardiography was used to measure MAP, SVR, cardiac output (CO), stroke volume (SV), and thoracic fluid content (TFC) at baseline and at 30, 60, and 120 min after application of nitroglycerin ointment. Mixed effects regression models with random slope and random intercept were used to analyze changes in hemodynamic parameters from baseline to 30, 60, and 120 min after adjusting for age, sex, and final ED diagnosis of AHF.
RESULTS: Sixty-four subjects with mean age of 55 years (interquartile range, 48-67 years) were enrolled; 59% were male. In the adjusted analysis, MAP and TFC decreased after application of nitroglycerin ointment (p=0.001 and p=0.043, respectively). Cardiac index, CO, SVR, and SV showed no change (p=0.113, p=0.085, p=0.570, and p=0.076, respectively) over time.
CONCLUSIONS: Among ED patients who are treated with nitroglycerin ointment, MAP and TFC decrease over time. However, other hemodynamic parameters do not change after application of nitroglycerin ointment in these patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  heart failure; impedance cardiography; nitroglycerin

Mesh:

Substances:

Year:  2014        PMID: 24698507      PMCID: PMC4112004          DOI: 10.1016/j.jemermed.2014.01.026

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  17 in total

1.  Transthoracic impedance accurately estimates pulmonary wedge pressure in patients with decompensated chronic heart failure.

Authors:  Gabriella Malfatto; Simonetta Blengino; Giovanni B Perego; Giovanna Branzi; Alessandra Villani; Mario Facchini; Gianfranco Parati
Journal:  Congest Heart Fail       Date:  2011-09-14

2.  Acute heart failure syndromes: current state and framework for future research.

Authors:  Mihai Gheorghiade; Faiez Zannad; George Sopko; Liviu Klein; Ileana L Piña; Marvin A Konstam; Barry M Massie; Edmond Roland; Shari Targum; Sean P Collins; Gerasimos Filippatos; Luigi Tavazzi
Journal:  Circulation       Date:  2005-12-20       Impact factor: 29.690

3.  Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid.

Authors:  A McAllister; H Mosberg; J A Settlage; J A Steiner
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

4.  Hemodynamic effects of nitroglycerin ointment in congestive heart failure.

Authors:  W R Taylor; J S Forrester; P Magnusson; T Takano; K Chatterjee; H J Swan
Journal:  Am J Cardiol       Date:  1976-10       Impact factor: 2.778

5.  Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).

Authors:  P R Imhof; T Vuillemin; A Gérardin; A Racine; P Müller; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure.

Authors:  P W Armstrong; J A Armstrong; G S Marks
Journal:  Am J Cardiol       Date:  1980-10       Impact factor: 2.778

7.  Sustained effects of nitroglycerin ointment in patients with angina pectoris.

Authors:  N Reichek; R E Goldstein; D R Redwood; S E Epstein
Journal:  Circulation       Date:  1974-08       Impact factor: 29.690

Review 8.  Nitrate delivery systems in perspective. A decade of progress.

Authors:  J Abrams
Journal:  Am J Med       Date:  1984-06-22       Impact factor: 4.965

Review 9.  Vasodilators in the management of acute heart failure.

Authors:  Uri Elkayam; Munir Janmohamed; Munira Habib; Parta Hatamizadeh
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

10.  Hemodynamic effects of nitroglycerin in acute myocardial infarction.

Authors:  D O Williams; E A Amsterdam; D T Mason
Journal:  Circulation       Date:  1975-03       Impact factor: 29.690

View more
  1 in total

1.  Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea.

Authors:  Adel Sekma; Khaoula Bel Haj Ali; Camilia Jeddi; Nadia Ben Brahim; Nasri Bzeouich; Imen Gannoun; Imen Trabelssi; Kamel Laouiti; Mohamed Habib Grissa; Kaouthar Beltaief; Dridi Zohra; Zorgati Asma; Boukadida Lotfi; Youssef Rym; Houda Ben Soltane; Mezgar Zied; Khrouf Mariem; Mohamed Amine Msolli; Boukef Riadh; Wahid Bouida; Hamdi Boubaker; Semir Nouira
Journal:  Clin Cardiol       Date:  2021-06-02       Impact factor: 2.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.